Conservative XXXX treatment: analysis of cosmetic results and the role of concomitant adjuvant chemotherapy.

@entity1 @entity632 @entity82 @entity0 @entity2910 @entity786 @entity1487
Fifty-eight @entity1 conservatively treated for T1 @entity0 are analyzed for cosmetic outcome; 17 had concomitant adjuvant combination chemotherapy ( @entity786 , @entity632 , 5 @entity1487 ). The results are evaluated by clinical criteria and a quantitative measurement by use of light field projection at 33 months median follow-up. Surgery consisted of lumpectomy and axillary dissection; radiotherapy was given to the breast only except for additional internal mammary irradiation in central and medial lesions. (50 Gy whole breast, 64 Gy electron/photon boost). Questionnaires are used for inquiry on @entity1 experience: 88% of the @entity1 experienced a good to excellent cosmetic outcome. According to the panel only 64% show a good to excellent cosmesis. Panel-scores on asymmetry are compared with quantitative measurements. More @entity2910 and probably a higher degree of @entity82 in the boost area is found in the chemotherapy group. No differences in cosmetic outcome, complication rates, and @entity1 experiences are seen. Results are compared with published data.
